IGF2 and benign neoplasm of adrenal gland: Among markers that can distinguish ACC from benign adrenal neoplasms, insulin-like growth factor 2 (IGF-2) is the most frequently studied, with overexpression in up to 90% of ACC (see also sections ‘Methylome’, ‘Transcriptome’ and ‘DNA mutations’).